IRAK1 Duplication in MECP2 Duplication Syndrome Does Not Increase Canonical NF-κB-Induced Inflammation

Ilona Gottschalk1,2, Uwe Kölsch3, Dimitrios L Wagner2,4,5,6

  • 1Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.

Abstract

Insights

Patients with MECP2/IRAK1 duplication syndrome do not exhibit heightened NF-κB signaling, suggesting that suppressing this pathway may not benefit them. This finding impacts potential treatments for severe infections and inflammation in these patients.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • MECP2/IRAK1 duplication syndrome is characterized by developmental issues, neurological deficits, and severe, recurrent infections often leading to fatal respiratory complications.
  • The underlying cause of excessive inflammation in these patients remains unclear, representing a significant unmet clinical need.
  • Investigating the role of IRAK1 overexpression in inflammatory pathways is crucial for understanding disease pathogenesis.

Purpose of the Study:

  • To investigate the influence of IRAK1 overexpression on canonical NF-κB signaling as a potential driver of excessive inflammation in MECP2/IRAK1 duplication syndrome.
  • To determine if increased NF-κB signaling is present in patients with this syndrome.
  • To inform potential therapeutic strategies targeting inflammatory pathways.

Main Methods:

  • Assessed NF-κB signaling by measuring proinflammatory cytokine production (IL-6, IL-8).
  • Evaluated IRAK1 and IκBα degradation patterns following stimulation with IL-1β and TLR agonists.
  • Utilized SV40-immortalized fibroblasts, peripheral blood mononuclear cells (PBMCs), and whole blood from 9 patients and healthy controls.

Main Results:

  • No significant difference in IL-6 and IL-8 production was observed between patients and controls in response to IL-1β and TLR agonists in fibroblasts, PBMCs, and whole blood.
  • IRAK1 phosphorylation and degradation, as well as IκBα degradation, showed equivalent patterns in both patients and controls upon IL-1β stimulation.
  • Canonical NF-κB signaling activation was not elevated in MECP2/IRAK1-duplicated patients across all tested cell types.

Conclusions:

  • Patients with MECP2/IRAK1 duplication syndrome do not exhibit increased canonical NF-κB signaling.
  • Therapeutic suppression of the canonical NF-κB pathway is unlikely to benefit these patients.
  • Further research is needed to identify the mechanisms driving inflammation in MECP2/IRAK1 duplication syndrome.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.3K